FN Clarivate Analytics Web of Science
VR 1.0
PT J
ID STEM-CELLS; GENE-EXPRESSION; SYSTEM REGENERATION; EXCRETORY SYSTEM;
   RNA-SEQ; REGULATORS; MAINTENANCE; EVOLUTION
ER

PT J
ID STEM-CELLS; GENE-EXPRESSION; RNA-SEQ; REGENERATION; PLURIPOTENCY;
   PLANARIANS; SYSTEM
ER

PT J
ID FIBROSIS DEVELOPMENT; RNA-SEQ; ATLAS; ROLES
ER

PT J
ID CANONICAL CORRELATION-ANALYSIS; RNA-SEQ DATA; GENE-EXPRESSION DATA;
   LINEAGE COMMITMENT; STEM-CELLS; MAP; CLASSIFICATION; IDENTIFICATION;
   HETEROGENEITY; VISUALIZATION
ER

PT J
ID SQUAMOUS-CELL CARCINOMA; INTRATUMOR GENETIC-HETEROGENEITY; COPY NUMBER
   ALTERATIONS; LIM PROTEIN AJUBA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL
   CANCER; GENOMIC ANALYSIS; SIGNALING PATHWAY; TP53 MUTATIONS; ALTERED
   FIELDS
ER

PT J
DE Long non-coding RNAs; Glioblastoma multiforme; Signature; Prognosis;
   Immune
ID LONG NONCODING RNA; LARGE GENE LISTS; B-CELL LYMPHOMA; CANCER
   INITIATION; LNCRNA BIOMARKERS; TUMOR-SUPPRESSOR; FUNCTIONAL-ROLE;
   SURVIVAL; GLIOMA; PROGRESSION
ER

PT J
ID NICOTINIC ACETYLCHOLINE-RECEPTORS; SHORT NEUROPEPTIDE-F; GENE-EXPRESSION
   DATA; MUSHROOM BODY; NERVOUS-SYSTEM; CENTRAL COMPLEX; SYNAPTIC CLEFTS;
   ODOR MEMORY; NEURONS; MELANOGASTER
ER

PT J
DE Brain parcellation; Resting-state functional MRI; Cerebral cortex;
   Functional neuroimaging; Model selection; Network analysis
ID RESTING-STATE FMRI; CONNECTIVITY-BASED PARCELLATION; GRAPH-THEORETICAL
   ANALYSIS; HUMAN CONNECTOME PROJECT; HUMAN CORTICAL ANATOMY; SMALL-WORLD
   NETWORKS; FUNCTIONAL CONNECTIVITY; CLUSTER-ANALYSIS; STRUCTURAL
   CONNECTIVITY; CINGULATE CORTEX
ER

PT J
ID INTEGRATED GENOMIC CHARACTERIZATION; UNKNOWN PRIMARY; CARCINOMA; BREAST;
   SIMILARITIES; SIGNATURE; DISCOVERY; ACCURATE; TOOL
ER

PT J
ID COMPREHENSIVE MOLECULAR CHARACTERIZATION; LANDSCAPE; GENES; EXPRESSION;
   SIGNATURES; MUTATIONS
ER

PT J
ID GENE-EXPRESSION SIGNATURE; EMBRYONIC STEM; CONNECTIVITY MAP;
   SELF-RENEWAL; ANNEXIN 1; CANCER; CELLS; TUMOR; OVEREXPRESSION;
   PROLIFERATION
ER

PT J
ID SOMATIC MUTATIONS; MICROSATELLITE INSTABILITY; PROTEIN-STRUCTURE; PD-1
   BLOCKADE; BREAST-CANCER; OPEN-LABEL; GENOMES; LANDSCAPE; VARIANTS;
   MELANOMA
ER

PT J
DE exosomes; EGFRvIII; liquid biopsy; circulatory biomarkers; oncology
ID EXTRACELLULAR VESICLES; MOLECULAR HETEROGENEITY; GLIOBLASTOMA;
   MICROVESICLES; THERAPY; INFORMATION; EGFRVIII; TUMORS; CELLS; RNA
ER

PT J
DE RNA Interference; Hepatic Carcinogenesis; Cell Cycle; Tumorigenesis
ID HEPATOCELLULAR-CARCINOMA; CELL-DIVISION; ANEUPLOIDY; FAILURE; CANCER;
   ANLN; TRANSFORMATION; PROGNOSIS; RHOA
ER

PT J
ID NEPHRON PROGENITOR POPULATION; PLURIPOTENT STEM-CELLS; MAMMALIAN KIDNEY;
   BRANCHING MORPHOGENESIS; GENE-EXPRESSION; RENAL PELVIS; MICRODISSECTION;
   NUMBER; IDENTIFICATION; NEPHROGENESIS
ER

PT J
DE glioblastoma biomarker; NF kappa B;
   O-6-methylguanine-DNA-methyltransferase (MGMT); PDGFRA; TERT
ID NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II; TEMOZOLOMIDE; GLIOMA; GENE;
   CELLS; RADIOTHERAPY; COMBINATION; TRIAL; METHYLTRANSFERASE
ER

PT J
ID FIBROBLAST-LIKE SYNOVIOCYTES; CHRONIC INFLAMMATION; HIGH-THROUGHPUT;
   STROMAL CELLS; TRANSCRIPTOMICS; EXPRESSION; CARTILAGE; CLASSIFICATION;
   DESTRUCTION; ACTIVATION
ER

PT J
ID CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM-CELLS; BMX TYROSINE KINASE;
   ENDOTHELIAL-CELLS; GENE-EXPRESSION; RNA-SEQ; CAPILLARY PERICYTES;
   BARRIER TRANSPORT; BETA-PEPTIDE; SINGLE CELLS
ER

PT J
ID EMBRYONIC STEM-CELLS; MESSENGER-RNA-SEQ; SINGLE-CELL; GENE-EXPRESSION;
   CHROMATIN ACCESSIBILITY; MAMMARY-GLAND; IN-SITU; TUMOR; DIFFERENTIATION;
   RECONSTRUCTION
ER

PT J
ID AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; MYELOID CELLS;
   APOLIPOPROTEIN-E; GENE-EXPRESSION; ASSOCIATION; NEURODEGENERATION;
   PATHOLOGY; DISEASE; MOUSE
ER

PT J
DE Tumor Progression; Immune Cell Migration; Anti-tumor Immune Response;
   Infiltration
ID MYELOID CELLS; ANTICANCER THERAPIES; ENDOTHELIAL-CELLS; PLUS
   BEVACIZUMAB; CANCER; MACROPHAGES; METASTASIS; PATHWAYS; RECEPTOR; TRIAL
ER

PT J
ID OLIGOTROPHIC OCEAN; PROTEIN FAMILIES; DNA VIRUSES; GENOME; BIOGEOGRAPHY;
   ALIGNMENT; PLANKTON; SEA; COMMUNITIES; HIGHLIGHTS
ER

PT J
ID TISSUE GROWTH-FACTOR; CELL CONTACT INHIBITION; EMERGING ROLE;
   CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION;
   SIGNALING PATHWAY; BREAST-CANCER; LIVER-CANCER; MICRORNA-375
ER

PT J
ID GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; GWAS
   CATALOG; DISEASE; DISCOVERY; DATABASE; DRIVERS
ER

PT J
ID PROTEOMICS; PLATFORM; ARCHIVE; UPDATE; EPIGENOMES; RESOURCES; GENOMICS;
   REACTOME; PLANTS
ER

PT J
ID MHC CLASS-I; PUBLIC PROTEOMICS DATA; MASS-SPECTROMETRY;
   CANCER-IMMUNOTHERAPY; T-CELLS; ANTIGEN PRESENTATION; PEPTIDE
   REPERTOIRES; EPITOPE PREDICTION; IDENTIFICATION; MOLECULES
ER

PT J
DE Breast cancer; Triple negative; Immune therapy
ID EPIDEMIOLOGY; PD-L1; BASAL
ER

PT J
DE miRNA; TCGA; hepatocellular carcinoma; prognosis; biomarker
ID CANCER GENOME ATLAS; SQUAMOUS-CELL CARCINOMA; FALSE DISCOVERY RATE;
   THERAPEUTIC TARGETS; EXPRESSION PROFILES; NONCODING RNA; BREAST-CANCER;
   DOWN-REGULATION; BLADDER-CANCER; LUNG-CANCER
ER

PT J
DE Genomic profiling; Mutational burden; Papillary renal cell carcinoma
ID LUNG-CANCER; UROTHELIAL CARCINOMA; PHASE-2 TRIAL; PRIMARY TUMOR; MET;
   SUNITINIB; CRIZOTINIB; MUTATION; SENSITIVITY; CONCORDANCE
ER

PT J
DE spatial proteomics; transcriptomics; antibodies; immunohistochemistry;
   immunofluorescence; single-cell; protein expression
ID TRANSCRIPTOMICS; LOCALIZATION; IMMUNOFLUORESCENCE; INTEGRATION;
   VALIDATION; ANTIBODIES; DRAFT
ER

PT J
DE miR-1; Gastric cancer; Vascular endothelial growth factor A;
   Angiogenesis
ID HUMAN CHONDROSARCOMA; DOWN-REGULATION; BREAST-CANCER; COLON-CANCER;
   LUNG-CANCER; EXPRESSION; MIR-1; MET; ACTIVATION; CARCINOMA
ER

PT J
DE Liver Cancer; Genetics; Immune Response; Gene Regulation; COSMIC
ID BECKWITH-WIEDEMANN-SYNDROME; TGF-BETA; TUMOR SUPPRESSION; STEM-CELLS;
   HUMAN CANCER; LIVER; MICE; DISRUPTION; ACTIVATION; CARCINOGENESIS
ER

PT J
DE microRNA; microRNA-145-5p; microRNA-145-3p; passenger strand; head and
   neck squamous cell carcinoma; antitumor; myosin 1B
ID MICRORNA EXPRESSION SIGNATURE; DISEASE PROGRESSION MARKER; RESISTANT
   PROSTATE-CANCER; MYOSIN 1B; BLADDER-CANCER; DUAL STRANDS; MIGRATION;
   INVASION; PROMOTES; CLUSTER
ER

PT J
ID EMBRYONIC STEM-CELLS; WADDINGTONS EPIGENETIC LANDSCAPE; HUMAN BRAIN
   TRANSCRIPTOME; IN-SITU HYBRIDIZATION; RNA-SEQ DATA; GENE-EXPRESSION;
   SINGLE CELLS; MESSENGER-RNA; CHROMATIN ACCESSIBILITY; HEMATOPOIETIC STEM
ER

PT J
ID RITUXIMAB PLUS CYCLOPHOSPHAMIDE; SEQUENCING DATA; RNA-SEQ; SOMATIC
   MUTATIONS; EXPRESSION; CANCER; GENOME; DISCOVERY; PRIORITIZATION;
   CLASSIFICATION
ER

PT J
ID CELL TRANSCRIPTOMICS; GENE-EXPRESSION; NEURONS; ACTIVATION; DYNAMICS;
   GENOMICS
ER

PT J
DE Histopathology; Hepatocellular carcinoma; Mutations; Molecular
   carcinogenesis
ID POTENTIAL THERAPEUTIC TARGETS; STEATOHEPATITIC FEATURES; GADOXETIC ACID;
   EXPRESSION; ANGIOPOIETIN-2; METASTASIS; LANDSCAPE; DISEASE
ER

PT J
DE Circular RNA_LARP4; miR-424-5p; LATS1; Invasion; Gastric cancer
ID HIPPO SIGNALING PATHWAY; HEPATOCELLULAR-CARCINOMA; COACTIVATORS YAP;
   NONCODING RNAS; UP-REGULATION; GROWTH; SUPPRESSOR; CHEMORESISTANCE;
   METASTASIS; SURVIVAL
ER

PT J
ID GENE-EXPRESSION; MICRORNA BIOGENESIS; SEQUENCING DATA; REGULATORY SITES;
   NONCODING RNAS; CAP-ANALYSIS; START SITES; TRANSCRIPTION; GENOME; CANCER
ER

PT J
DE Immune Checkpoint; Virtual Microdissection; Molecular Subgroups; Immune
   Regulation
ID GENE-EXPRESSION; T-CELLS; PEMBROLIZUMAB; BIOMARKERS; SORAFENIB; TUMOR
ER

PT J
DE Molecular subtypes; Muscle-invasive bladder cancer; DNA alterations
ID TERT PROMOTER MUTATIONS; TRANSITIONAL-CELL CARCINOMA; SOMATIC ERCC2
   MUTATIONS; UROTHELIAL CARCINOMA; BREAST-CANCER; NEOADJUVANT
   CHEMOTHERAPY; EXPRESSION SIGNATURE; DISEASE RECURRENCE; INTRINSIC
   SUBTYPES; LUMINAL SUBTYPES
ER

PT J
ID CELL LUNG-CANCER; METASTATIC MELANOMA; DIFFERENTIAL GENE;
   ENDOTHELIAL-CELLS; CTLA-4 BLOCKADE; PD-1 BLOCKADE; T-CELLS; GENOME;
   RECEPTOR; LYMPHOCYTES
ER

PT J
ID CARCINOMA; EXPRESSION; RNA; IMPACT; LIVER; KI-67; ANLN
ER

PT J
ID NEMATODE CAENORHABDITIS-ELEGANS; MESSENGER-RNA-SEQ; GENE-EXPRESSION;
   NERVOUS-SYSTEM; GENOME; CONTIGUITY; PATHWAYS; CORTEX
ER

PT J
ID EPIGENETIC HETEROGENEITY; EPIGENOMIC SIGNATURES; RADIAL GLIA; HUMAN
   BRAIN; SPECIFICATION; DIVERSITY; GENOME
ER

PT J
ID RENAL-CELL CARCINOMA; T-CELLS; SOMATIC MUTATIONS; FRAMESHIFT MUTATIONS;
   METASTATIC MELANOMA; CHECKPOINT BLOCKADE; GENOMIC LANDSCAPE; CTLA-4
   BLOCKADE; SEQUENCING DATA; LUNG-CANCER
ER

PT J
ID INTRANUCLEAR-CASCADE CALCULATION; HADRONIC CALIBRATION; DETECTOR;
   NUCLEUS
ER

PT J
DE seed; dormancy; signal integration; distributed control; variability
ID ABSCISIC-ACID; GIBBERELLIN BIOSYNTHESIS; SIGNALING PATHWAYS;
   GERMINATION; THALIANA; GROWTH; CELL; GENE; TRANSCRIPTION; TRANSPORTER
ER

PT J
DE ABC transporter; acyl-ACP thioesterase; fungus; GPAT; Medicago
   truncatula; roots; symbiosis
ID FUNGUS GLOMUS-INTRARADICES; ACYL-ACP THIOESTERASES; GENE-EXPRESSION
   ATLAS; MEDICAGO-TRUNCATULA; PHOSPHATE TRANSPORTER; ABC TRANSPORTERS;
   GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; SUBSTRATE-SPECIFICITY;
   ARABIDOPSIS-THALIANA; CARBON METABOLISM
ER

PT J
ID SIGNAL PEPTIDES; HUMAN PROTEINS; CELL-LINES; LOCALIZATION; ATLAS;
   VALIDATION; ANTIBODIES; IMMUNOFLUORESCENCE; KNOWLEDGEBASE; PREDICTION
ER

PT J
DE nodule-specific cysteine-rich peptides; symbiosis; legume; nodule;
   nitrogen-fixing bacteroids
ID CYSTEINE-RICH PEPTIDES; GENE-EXPRESSION ATLAS; REPEAT-LACKING CLADE;
   RNA-SEQ DATA; MEDICAGO-TRUNCATULA; SINORHIZOBIUM-MELILOTI; PLANT
   PEPTIDES; RHIZOBIUM-MELILOTI; NODULE DEVELOPMENT; NITROGEN-FIXATION
ER

PT J
ID TUMOR-ASSOCIATED MACROPHAGES; MASS CYTOMETRY; GLIOMA PROGRESSION;
   T-CELLS; RNA-SEQ; CANCER-THERAPY; LUNG-CANCER; POLARIZATION; ACTIVATION;
   EXPRESSION
ER

PT J
ID TERTIARY LYMPHOID STRUCTURES; FLOW-CYTOMETRIC ANALYSIS; DENDRITIC CELLS;
   MYELOID CELLS; GENE-EXPRESSION; T-CELLS; RNA-SEQ; CANCER; MACROPHAGES;
   MICROENVIRONMENT
ER

PT J
ID BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; ASSISTED RADICAL
   CYSTECTOMY; TRANSITIONAL-CELL CARCINOMA; RANDOMIZED CLINICAL-TRIAL;
   QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; FLAT UROTHELIAL
   HYPERPLASIAS; FREQUENT FGFR3 MUTATIONS; GENOME-WIDE ASSOCIATION
ER

PT J
ID TUMOR-INFILTRATING LYMPHOCYTES; MUTANT IDH1; TGF-BETA;
   GLIOBLASTOMA-MULTIFORME; ANTITUMOR IMMUNITY; ADOPTIVE TRANSFER; MYELOID
   CELLS; SURVIVAL; EXPRESSION; GENE
ER

PT J
ID HIV-INFECTED PATIENTS; NON-INFERIORITY TRIAL; PROTEASE INHIBITOR
   MONOTHERAPY; OPEN-LABEL; TRIPLE TREATMENT; DUAL TREATMENT; NAIVE ADULTS;
   EFFICACY; THERAPY; EMTRICITABINE
ER

PT J
ID GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; PROMOTER USAGE; PR INTERVAL;
   TRANSCRIPTION; EVOLUTION; SEQ; ARCHITECTURE; ANNOTATION; LANDSCAPE
ER

PT J
ID MEMBRANE-PROTEIN 2A; LUNG-CANCER; LIGAND 1; NASOPHARYNGEAL CARCINOMA;
   TUMOR-IMMUNOTHERAPY; EXPRESSION; SURVIVAL; MICROENVIRONMENT;
   CLASSIFICATION; INFILTRATION
ER

PT J
ID SOMATIC MUTATION; CANCER; CELLS; DISCOVERY; BASE
ER

PT J
ID RNA-BINDING PROTEIN; SPORADIC PHEOCHROMOCYTOMA; SOMATIC MUTATIONS;
   GENE-EXPRESSION; STEM-CELLS; CANCER; TUMORS; CARCINOMA; RET;
   DIFFERENTIATION
ER

PT J
ID ADAPTIVE IMMUNE RESISTANCE; GAMMA SIGNAL-TRANSDUCTION; CELL LUNG-CANCER;
   ACQUIRED-RESISTANCE; ADVANCED MELANOMA; COPY NUMBER; THERAPY;
   PEMBROLIZUMAB; SENSITIVITY; ABERRATIONS
ER

PT J
ID METASTATIC MELANOMA; EXPRESSION PROFILES; IMMUNE CELLS; TUMOR;
   IMMUNOTHERAPY; GENOME; HETEROGENEITY; NEOANTIGENS; SENSITIVITY;
   MECHANISMS
ER

PT J
DE PD-1; PD-L1; PD-L2; melanoma; mutational load
ID RENAL-CELL CARCINOMA; CD8(+) T-CELLS; PD-L1 EXPRESSION; IMMUNE CELLS;
   POOR-PROGNOSIS; LIGAND 1; CLINICAL-SIGNIFICANCE; ANALYSIS REVEALS;
   CTLA-4 BLOCKADE; CANCER
ER

PT J
DE checkpoint blockade; neoantigens; immunotherapy; T-cell inflammation;
   tumor microenvironment
ID ANTI-PD-1 ANTIBODY; PERIPHERAL-BLOOD; DENDRITIC CELLS; LUNG-CANCER;
   NIVOLUMAB; BLOCKADE; NEOANTIGENS; IPILIMUMAB; RESISTANCE; DOCETAXEL
ER

PT J
ID METASTATIC MELANOMA; CTLA-4 BLOCKADE; CANCER; IPILIMUMAB; SENSITIVITY;
   MUTATIONS; ANTIBODY
ER

PT J
ID LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION;
   CELL-PROLIFERATION; POOR-PROGNOSIS; HISTONE METHYLTRANSFERASE; DNA
   METHYLATION; MESSENGER-RNA; LUNG-CANCER; EXPRESSION; GROWTH
ER

PT J
ID RNA-SEQ REVEALS; GENE-EXPRESSION ANALYSIS; CIRCULATING TUMOR-CELLS;
   COPY-NUMBER VARIATION; EMBRYONIC STEM-CELLS; MESSENGER-RNA; SEQUENCING
   DATA; MASS CYTOMETRY; DIFFERENTIAL EXPRESSION; MAMMALIAN-CELLS
ER

PT J
ID EMBRYONIC STEM-CELLS; RNA-SEQ; BETA-CELLS; INSULIN-SECRETION;
   GENE-EXPRESSION; ISLET TRANSCRIPTOME; OXIDATIVE STRESS; MOUSE ISLETS;
   GLUCOSE; DIFFERENTIATION
ER

PT J
ID TUMOR HETEROGENEITY; CANCER; HETEROZYGOSITY; ABERRATIONS; ALGORITHM;
   SAMPLES
ER

PT J
ID GENE-EXPRESSION PROFILES; IASLC/ATS/ERS CLASSIFICATION; PULMONARY
   ADENOCARCINOMAS; INTERNATIONAL ASSOCIATION; CARCINOMA; DIAGNOSIS;
   INTEROBSERVER; TISSUE; MODEL; REPRODUCIBILITY
ER

PT J
ID HUMAN PREFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; ADULT HUMAN BRAIN;
   GENE-EXPRESSION; RHESUS-MONKEY; VISUAL-CORTEX; SYNAPTIC DEVELOPMENT;
   POSITIVE SELECTION; MOLECULAR PATHWAYS; RNA-SEQ
ER

PT J
ID CANCER-IMMUNOTHERAPY; ANTI-PD-L1 ANTIBODY; GENE SIGNATURE; PD-1
   BLOCKADE; T-CELLS; METASTASIS; EXPRESSION; RESISTANCE; MELANOMA;
   IMMUNOSUPPRESSION
ER

PT J
ID NONCODING RNA; BREAST-CANCER; NUCLEIC-ACIDS; MESSENGER-RNA; PLASMA;
   BLOOD; MICRORNAS; IDENTIFICATION; MARKERS; TOOL
ER

PT J
DE Deconvolution; DNA methylation; Epigenetics; Non-negative matrix
   factorization
ID EPIGENOME-WIDE ASSOCIATION; SURROGATE VARIABLE ANALYSIS;
   GENE-EXPRESSION; BREAST-CANCER; CORD BLOOD; RHEUMATOID-ARTHRITIS; MATRIX
   FACTORIZATION; ENDOTHELIAL-CELLS; ARSENIC EXPOSURE; IN-UTERO
ER

PT J
ID CELL LUNG-CANCER; COLORECTAL-CANCER; READ ALIGNMENT; RNA-SEQ; MUTATIONS;
   GENE; RESISTANCE; GEFITINIB; DISCOVERY; FRAMEWORK
ER

PT J
ID CELL LUNG-CANCER; LONG-TERM SAFETY; PD-1 BLOCKADE; RECEIVING NIVOLUMAB;
   UNTREATED MELANOMA; CTLA-4 BLOCKADE; PATIENTS PTS; MUTATIONS; SURVIVAL;
   EXPRESSION
ER

PT J
ID MICROSATELLITE INSTABILITY; CELL-PROLIFERATION; TUMOR-GROWTH;
   COLON-CANCER; MICRORNA; SMAD4; IDENTIFICATION; PROGNOSIS; INVASION;
   DISEASE
ER

PT J
ID CELL LUNG-CANCER; IMMUNE-RELATED RESPONSE; UNTREATED MELANOMA;
   PROGRAMMED DEATH-1; RANDOMIZED-TRIAL; CTLA-4 BLOCKADE; BLADDER-CANCER;
   PD-1 BLOCKADE; SOLID TUMORS; NIVOLUMAB
ER

PT J
ID EARLY MOUSE EMBRYOS; GENE-EXPRESSION; EUTHERIAN MAMMALS; STEM-CELLS;
   INACTIVATION; DIFFERENTIATION; BLASTOCYST; FGF; SEGREGATION; EVOLUTION
ER

PT J
DE PD-L1; Adaptive resistance; Ovarian cancer
ID DEATH-LIGAND 1; ANTI-PD-L1 ANTIBODY; IMMUNE RESISTANCE; CARCINOMA;
   LYMPHOCYTES; BLOCKADE; RESPONSES; SURVIVAL; PATHWAY; SAFETY
ER

PT J
ID BREAST-CANCER; PROSTATE-CANCER; MEVALONATE PATHWAY;
   HEPATOCELLULAR-CARCINOMA; DIETARY-CHOLESTEROL; TUMOR ANGIOGENESIS;
   SQUALENE EPOXIDASE; COLORECTAL-CANCER; CELL-DEATH; STATIN USE
ER

PT J
DE Glioma; Long noncoding RNAs; HOXA11-AS; HOXA cluster; Cell cycle
ID LONG-NONCODING RNA; HEPATOCELLULAR-CARCINOMA; GLIOBLASTOMA; CANCER;
   INVASION; GROWTH; SUPPRESSES; EXPRESSION; PROGNOSIS; HOTAIR
ER

PT J
ID TUMOR-INFILTRATING LYMPHOCYTES; NEWLY-DIAGNOSED GLIOBLASTOMA; CANCER
   GENOME ATLAS; LONG-TERM SURVIVAL; PHOTODYNAMIC THERAPY; ANTITUMOR
   IMMUNITY; RECURRENT GLIOBLASTOMA; CALRETICULIN EXPOSURE; TEMOZOLOMIDE;
   IMMUNOTHERAPY
ER

PT J
ID F-BOX PROTEINS; CELL-GROWTH; ARABIDOPSIS-THALIANA; INFLORESCENCE
   ARCHITECTURE; TRANSCRIPTOME ATLAS; SPECIALIZED ZONES; ANALYSIS TOOLKIT;
   DATA SETS; ETHYLENE; GENOMICS
ER

PT J
ID RENAL-CELL CARCINOMA; CHAIN AMINO-ACIDS; SOMATIC MUTATIONS; SEQUENCING
   DATA; DEPLETION; TRANSCRIPTION; METABOLISM; INNATE; BIOGENESIS;
   MECHANISMS
ER

PT J
DE KRAS; cancer metabolism; pancreatic cancer; tumor immune modulation
ID REGULATORY T-CELLS; MYELOID SUPPRESSOR-CELLS; TUMOR-INFILTRATING
   MACROPHAGES; NEOPLASTIC PRECURSOR LESIONS; PAPILLARY MUCINOUS NEOPLASM;
   COLONY-STIMULATING FACTOR; RAS-DRIVEN TUMORIGENESIS; K-RAS; ONCOGENIC
   KRAS; INTRAEPITHELIAL NEOPLASIA
ER

PT J
DE land plant evolution; Physcomitrella patens; transcriptome atlas; TCP;
   branching; tip growth
ID GENE-EXPRESSION; CELL-GROWTH; KNOX GENES; POLLEN MATURATION; SHOOT
   DEVELOPMENT; ROOT HAIRS; MOSS; ARABIDOPSIS; PROTEINS; DOMAIN
ER

PT J
DE cancer stem cells; glioblastoma; immune suppression; PD-1; PD-L1
ID TUMOR-INFILTRATING LYMPHOCYTES; NEWLY-DIAGNOSED GLIOBLASTOMA; REGULATORY
   T-CELLS; ADVANCED MELANOMA; B7-H1 EXPRESSION; HUMAN GLIOMAS;
   LUNG-CANCER; BLOCKADE; SAFETY; IMMUNOSUPPRESSION
ER

PT J
ID TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; ULCERATIVE-COLITIS; FACTOR-ALPHA;
   INDUCTION THERAPY; RANDOMIZED-TRIAL; INFLIXIMAB; ADALIMUMAB;
   MAINTENANCE; REMISSION
ER

PT J
ID TERT PROMOTER MUTATIONS; PILOCYTIC ASTROCYTOMA; GENOMIC ANALYSIS;
   BRAIN-TUMORS; GRADE II; GLIOBLASTOMA; EXPRESSION; CANCER; CELLS; IDH1
ER

PT J
ID HIPPOCAMPAL-FORMATION; FUNCTIONAL DOMAINS; CELL-TYPES; ORGANIZATION;
   DORSAL; PROJECTIONS; AMYGDALA; REGION; ATLAS; AREAS
ER

PT J
ID HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; GROWTH; HYPOXIA; CARBOXYLATION;
   BIOMARKERS; THERAPY; PATHWAY; PROTEIN; MODEL
ER

PT J
ID MICROARRAY; TRANSCRIPT
ER

PT J
ID BRAF V600E MUTATION; TALL-CELL VARIANT; NEEDLE-ASPIRATION BIOPSY;
   TERM-FOLLOW-UP; FOLLICULAR VARIANT; BRAF(V600E) MUTATION;
   SURGICAL-TREATMENT; CLINICAL-FEATURES; CARCINOMA; ASSOCIATION
ER

PT J
DE Extracellular matrix; Matrisome; MatrisomeDB; ECM atlas; Bioinformatics;
   Proteomics
ID FUNCTIONAL GENOMICS EXPERIMENTS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY;
   QUANTITATIVE PROTEOMICS; HEPARAN-SULFATE; COMPLEX TISSUES; PROTEINS;
   DATABASE; CARTILAGE; REVEALS
ER

PT J
ID COLORECTAL-CANCER; LUNG-CANCER; ASPIRIN; TUMOR; RISK
ER

PT J
DE 5-hydroxymethylcytosine; CpG sites; DNA methylation; epigenetics;
   microarray; paraffin; validation
ID SUPER-ENHANCERS; CELL IDENTITY; CANCER; SUSCEPTIBILITY; EPIGENETICS;
   CHROMATIN; DISEASE; GENES; ATLAS; MAP
ER

PT J
ID LARGE GENE LISTS; CLONAL EVOLUTION; SEQUENCING DATA; WHOLE-GENOME;
   ESOPHAGEAL ADENOCARCINOMA; LUNG ADENOCARCINOMA; CELL-POPULATIONS;
   BREAST-CANCER; MUTATIONS; DIVERSITY
ER

PT J
ID IMMUNOTHERAPY; MUTATIONS
ER

PT J
ID EPIGENETIC REGULATION; EXPRESSION; TRANSCRIPTOME; PROGRESSION;
   ANNOTATION; REVEALS; DISEASE; BIOLOGY
ER

PT J
ID ESTROGEN-RECEPTOR BINDING; E-CADHERIN EXPRESSION; PROSTATE-CANCER;
   TRANSCRIPTION FACTORS; RNA-SEQ; FOXA1; CARCINOMA; TUMORS; CDH1;
   SIGNATURES
ER

PT J
DE Cancer Genetics; Cancer Genomics; Gastric Cancer
ID HELICOBACTER-PYLORI CAGA; EPSTEIN-BARR-VIRUS; E-CADHERIN;
   EPITHELIAL-CELLS; DNA METHYLATION; CANCER PATIENTS; POOR-PROGNOSIS;
   MICROSATELLITE INSTABILITY; GASTROINTESTINAL-TRACT; TRANSCRIPTION
   FACTORS
ER

PT J
ID LONG NONCODING RNAS; GENOME ATLAS; SEQ DATA; DATABASE; TRANSCRIPTOME;
   EXPRESSION; LANDSCAPE; CARCINOMA; RESOURCE; DISEASE
ER

PT J
ID MIXED-LINEAGE LEUKEMIA; LI-FRAUMENI-SYNDROME; HOX GENE-EXPRESSION;
   METHYLTRANSFERASE ACTIVITY; HISTONE METHYLTRANSFERASE; MLL; MENIN;
   TRANSCRIPTION; INHIBITORS; BINDING
ER

PT J
ID CODING ENVELOPE GENES; HUMAN BREAST-CANCER; CELL LUNG-CANCER; HERV-K;
   CPG METHYLATION; OVARIAN-CANCER; NONCODING RNA; PD-1 BLOCKADE; HUMAN
   GENOME; TUMOR-CELLS
ER

PT J
DE glioblastoma; immune checkpoint; programmed death 1; programmed death
   ligand 1
ID NEWLY-DIAGNOSED GLIOBLASTOMA; RECURRENT MALIGNANT GLIOMAS; SQUAMOUS-CELL
   CARCINOMA; PD-L1 EXPRESSION; ADVANCED MELANOMA; BRAIN METASTASES; B7-H1
   EXPRESSION; BREAST-CANCER; PHASE-I/II; IPILIMUMAB
ER

PT J
DE human brain; single cells; RNAseq; neurons; interneurons
ID MHC CLASS-I; GENE-EXPRESSION; CEREBRAL-CORTEX; RNA-SEQ; NEURONS; MOUSE;
   CNS; INTERNEURONS; HIPPOCAMPUS; PROTEIN
ER

PT J
ID EMBRYONAL CARCINOMA-CELLS; MESSENGER-RNA; EXON CIRCULARIZATION; MOUSE
   TESTIS; DROSOPHILA; ELEMENTS; GENOME; BIOGENESIS; REVEALS; REPEATS
ER

PT J
ID RNA-SEQ; HUMAN GENOME; IN-VITRO; TRANSPOSITION; CONTIGUITY; EXPRESSION;
   FATE
ER

PT J
ID SINGLE-CELL; RNA-SEQ; MAMMALIAN RETINA; AMACRINE CELLS; DIGITAL PCR;
   GENE; DNA; CRYSTALLIN; LENS
ER

PT J
ID ANNELID PLATYNEREIS-DUMERILII; EXPRESSION PATTERNS; MARINE ZOOPLANKTON;
   COMMON ORIGIN; IN-SITU; EVOLUTION; GENES; RESOLUTION; INSIGHTS; LARVAE
ER

PT J
ID SELECTIVE INHIBITOR; CLINICAL-TRIALS; ONCOLOGY; PALBOCICLIB; ALECTINIB;
   GENOMICS; AZD4547; TARGETS; POTENT; BAR
ER

PT J
ID TRANSCRIPTIONAL ACTIVATOR; NETWORK ANALYSIS; SEED-DEVELOPMENT;
   GENE-EXPRESSION; ZEA-MAYS; CORRELATION-COEFFICIENT; DOUBLE
   FERTILIZATION; NUTRIENT ALLOCATION; FATE SPECIFICATION; PROTEIN
ER

PT J
ID PLURIPOTENT STEM-CELLS; FUNCTIONAL MATURATION; CORTICAL DEVELOPMENT;
   MOUSE MODEL; IN-VIVO; NEURONS; DIFFERENTIATION; INTERNEURONS; BRAIN;
   NEUROGENESIS
ER

PT J
ID CHROMATIN INTERACTIONS; ACTIVATION; RNAS; ATLAS
ER

PT J
ID NF-KAPPA-B; GROWTH-FACTOR-RECEPTOR; AJUBA FAMILY PROTEINS; CANCER
   GROWTH; ACTIVATION; EXPRESSION; TRAF3; EGFR; CLASSIFICATION; RESISTANCE
ER

PT J
ID HEAVY-ION COLLISIONS; BARREL CALORIMETER; TRANSVERSE FLOW;
   CROSS-SECTIONS; BEAM TESTS; PHOTOPRODUCTION; HERA; FRAGMENTATION;
   GENERATORS; SIMULATION
ER

PT J
ID ACINAR-CELL TRANSDIFFERENTIATION; IN-VITRO EXPANSION; ONCOGENIC KRAS;
   EXPRESSION PROFILES; PROGENITOR CELLS; ADENOCARCINOMA; MICE; NEOPLASIA;
   PROMOTES; IDENTIFICATION
ER

PT J
ID ANALYSIS GENE-EXPRESSION; CAP-ANALYSIS; TRANSCRIPTIONAL LANDSCAPE;
   FUNCTIONAL ANNOTATION; NATIONAL CENTER; HUMAN GENOME; RNA-SEQ; DATABASE;
   ONTOLOGIES; MOUSE
ER

PT J
DE Machine learning; Cancer susceptibility; Predictive models; Cancer
   recurrence; Cancer survival
ID BREAST-CANCER; NEURAL-NETWORKS; OUTCOME PREDICTION; FEATURE-SELECTION;
   DECISION-SUPPORT; RISK; RECURRENCE; MODEL; SUSCEPTIBILITY; SURVIVABILITY
ER

PT J
DE Breast cancer; Lymph nodes; Axillary nodes; Worldwide consensus;
   Guideline; Target volume delineation
ID COOPERATIVE GROUP DBCG; INTERNAL MAMMARY; INTEROBSERVER VARIATION;
   ADJUVANT RADIOTHERAPY; CT; ATLAS; IRRADIATION; HEART; POPULATION;
   DEFINITION
ER

PT J
DE cancer genomics; copy number alterations; mutations; next-generation
   sequencing; software
ID SNP ARRAYS; CANCER; EVOLUTION; SAMPLES; PURITY; PANEL
ER

PT J
ID MCCUNE-ALBRIGHT-SYNDROME; ACUTE MYELOID-LEUKEMIA; ACUTE
   LYMPHOBLASTIC-LEUKEMIA; GS-ALPHA MUTATIONS; MYELODYSPLASTIC SYNDROMES;
   BLOOD-CELLS; CANCER; GENE; INDIVIDUALS; VALIDATION
ER

PT J
ID SOMATIC MUTATIONS; GENE-EXPRESSION; CELL LYMPHOMAS; EBV-INFECTION;
   CANCER; EXOME; METHYLATION; SUBTYPES; KINASE; CLASSIFICATION
ER

PT J
ID ADP-GLUCOSE PYROPHOSPHORYLASE; PROGRAMMED CELL-DEATH; STARCH SYNTHASE-I;
   GENE-EXPRESSION; GENOME-WIDE; SEED DEVELOPMENT; ARABIDOPSIS SEED;
   MESSENGER-RNA; PROTEIN; RICE
ER

PT J
ID CELL LUNG-CANCER; ETV6-NTRK3 GENE FUSION; HUMAN-MELANOMA; ALK;
   IDENTIFICATION; CARCINOMA; MUTATIONS; PATHWAY; RET; PHOSPHORYLATION
ER

PT J
ID ISOCITRATE DEHYDROGENASE MUTATIONS; CHRONIC MYELOMONOCYTIC LEUKEMIA;
   MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE NEOPLASMS; OLDER PATIENTS;
   PRIMARY MYELOFIBROSIS; SOMATIC MUTATIONS; DOSE CYTARABINE; ADULT
   PATIENTS; GLIOMA-CELLS
ER

PT J
ID CANCER GENOME; CELL-LINES; MUTATIONS; EXPRESSION; GENE; REVEALS;
   CLASSIFICATION; INACTIVATION; LANDSCAPE; DISCOVERY
ER

PT J
ID RENAL-CELL CARCINOMA; OVARIAN CANCERS; BREAST-CANCER; LUNG CANCERS;
   SURVIVAL; EVEROLIMUS; MUTATIONS; MELANOMA; SAMPLES; MODELS
ER

PT J
ID ISLAND METHYLATOR PHENOTYPE; CHROMATIN REMODELING GENES; WERNER-SYNDROME
   PROTEIN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; DNA-POLYMERASE;
   BRAF MUTATION; COLON-CANCER; EXPRESSION; DEFICIENT
ER

PT J
ID GENOME-WIDE ASSOCIATION; PROFILES; VARIANTS
ER

PT J
ID ESTROGEN-RECEPTOR STATUS; BREAST-CANCER; QUANTIFICATION; EXPRESSION;
   ANTIBODY; CARCINOMA; PATHOLOGY; STAINS; MODEL; TOOL
ER

PT J
ID METASTATIC BREAST-CANCER; SQUAMOUS-CELL CARCINOMA; GENE COPY NUMBER;
   PROTEIN EXPRESSION; LUNG-CANCER; MOLECULAR CHARACTERIZATION; ENDOMETRIAL
   CARCINOMA; MICROARRAY ANALYSIS; PATHWAY ACTIVATION; MESSENGER-RNA
ER

PT J
ID CLASS-I ANTIGEN; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; EXOME ANALYSIS
   REVEALS; T-CELLS; INFILTRATING LYMPHOCYTES; ANTIBODY BLOCKADE;
   CHEMOTHERAPY PLUS; DOWN-REGULATION; OVARIAN-CANCER; MELANOMA
ER

PT J
ID OUTER SUBVENTRICULAR ZONE; RADIAL GLIAL-CELLS; HUMAN FETAL-BRAIN;
   CEREBRAL-CORTEX; NETWORK ANALYSIS; GENE-EXPRESSION; HUMAN NEOCORTEX;
   CORTICAL AREAS; MESSENGER-RNA; MOUSE-BRAIN
ER

PT J
ID MEDIAL PREFRONTAL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ;
   PARAFASCICULAR THALAMIC NUCLEUS; RAT VISUAL-CORTEX; THALAMOCORTICAL
   PROJECTIONS; EFFERENT PROJECTIONS; BARREL CORTEX; CORTICOTHALAMIC
   PROJECTIONS; CORTICAL PROJECTIONS; AFFERENT CONNECTIONS
ER

PT J
ID TUMOR-INFILTRATING LYMPHOCYTES; PROGRAMMED DEATH-1 LIGAND-1; T-CELL
   PROLIFERATION; CLINICAL-SIGNIFICANCE; B7-H1 EXPRESSION; CARCINOMA;
   MEMBER; IMMUNORESISTANCE; SUPERFAMILY; METASTASIS
ER

PT J
ID GENE-EXPRESSION; HUMAN GENOME; TRANSCRIPTION FACTORS; CAP-ANALYSIS;
   PROMOTER DIRECTIONALITY; REGULATORY SEQUENCES; ZEBRAFISH EMBRYOS; DNA
   METHYLATION; RNA-SEQ; ELEMENTS
ER

PT J
ID HUMAN TRANSCRIPTION FACTORS; GENE-EXPRESSION; HOMEOBOX GENE; MICE
   LACKING; HUMAN GENOME; INNER-EAR; DIFFERENTIATION; EVOLUTION; ONTOLOGY;
   CELLS
ER

PT J
ID HUMAN CANCERS; GENE FUSIONS; TUMOR-GROWTH; MUTATIONS; GENOMES; KINASE;
   FGFR
ER

PT J
ID INSULAR CORTEX; NERVOUS-SYSTEM; MOTOR CORTEX; STRUCTURAL CONNECTIVITY;
   OBJECT RECOGNITION; LIMBIC CONNECTIONS; CEREBRAL-CORTEX; BRAIN NETWORKS;
   RAT; CIRCUITS
ER

PT J
DE Gestational diabetes; Pregnancy; Hyperglycaemia in pregnancy; Maternal
   health; Diabetes
ID GESTATIONAL DIABETES-MELLITUS; DIAGNOSTIC-CRITERIA; RISK-FACTORS; WOMEN;
   POPULATION; TYPE-1; ASSOCIATION; GUIDELINES; MANAGEMENT; OUTCOMES
ER

PT J
ID HUMAN PROTEIN ATLAS; RNA-SEQ; TOOL; PLATFORM; PROJECT; CELLS
ER

PT J
ID HEPATOCELLULAR-CARCINOMA; GLOBAL RECONSTRUCTION; GENE-EXPRESSION;
   NETWORK; STEATOHEPATITIS; STEATOSIS; METHIONINE; PREDICTION; BIOMARKERS;
   PHYSIOLOGY
ER

PT J
ID TOOLS
ER

PT J
ID ESTROGEN-RECEPTOR; LIGAND-BINDING; AROMATASE INHIBITION; SOMATIC
   MUTATION; THERAPY; TAMOXIFEN; GENE; IDENTIFICATION; CONFORMATION;
   EXPRESSION
ER

PT J
ID ACUTE MYELOID-LEUKEMIA; SOMATIC POINT MUTATIONS; HUMAN BREAST; GENOMIC
   CHARACTERIZATION; COLORECTAL CANCERS; BRCA2 MUTATIONS; SEQUENCING DATA;
   OVARIAN-CANCER; CARCINOMA; PATHWAYS
ER

PT J
ID GENE-EXPRESSION; MOLECULAR SUBTYPES; BREAST-CANCER; T-CELLS; SURVIVAL;
   MICROENVIRONMENT; DIFFERENTIATION; QUANTIFICATION; PREDICTION; SIGNATURE
ER

PT J
ID SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; HEPATOCELLULAR-CARCINOMA;
   CERVICAL-CARCINOMA; INTEGRATION SITES; VIRUS; DNA; GENOME; HEAD; NECK
ER

PT J
ID RESPONSIVE FINGER PROTEIN; COSTIMULATOR MESSENGER-RNA; E3 UBIQUITIN
   LIGASE; SELF-RENEWAL; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR;
   NUCLEOTIDE-RESOLUTION; LET-7 MICRORNA; SOMATIC-CELLS; TARGET GENE
ER

EF